Effects of α- and β-adrenoceptor blockade on purine secretion induced by sympathetic nerve stimulation in the rat kidney

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 295-301

  Zaichuan, M I ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE DERIVATIVE; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYPOXANTHINE; HYPOXANTHINE DERIVATIVE; INOSINE; INOSINE DERIVATIVE; NORADRENALIN; PRAZOSIN; PROPRANOLOL; PURINE; URIC ACID; XANTHINE DERIVATIVE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; KIDNEY CELL; KIDNEY PERFUSION; MALE; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PURINE SYNTHESIS; RAT; SYMPATHETIC NERVE;

ADENOSINE; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; KIDNEY; MALE; PERFUSION; PURINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; SYMPATHETIC NERVOUS SYSTEM;

EID: 0344820765     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 2-receptor modulation of noradrenergic neurotransmission in rat kidney. Br J Pharmacol 121:1255-1262.
2. Burnstock G (1986) The changing face of autonomic neurotransmission. Acta Physiol Scand 126:67-91.
3. DiBona GF (1989) Sympathetic nervous system influences on the kidney Role in hypertension. Am J Hypertension 2:119S-124S.
4. DiBona GF (1991) Role of the renal nerves in hypertension. Semin Nephrol 11:503-511.
5. DiBona GF, Jones SY and Sawin LL (1996) Renal sympathetic neural mechanisms as intermediate phenotype in spontaneously hypertensive rats. Hypertension 27: 626-630.
6. Dubey RK, Gillespie DG, Mi Z and Jackson EK (1996a) Cardiac fibroblasts metabolize cyclic AMP to generate adenosine (Abstract). Hypertension 28:524.
7. Dubey RK, Gillespie DG, Mi Z and Jackson EK (1997) Cyclic AMP-adenosine pathway inhibits glomerular mesangial cell growth. Hypertension 30:506 (abstract).
8. Dubey RK, Gillespie DG, and Jackson EK (1998) Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells. Hypertension 31:296-302.
9. Dubey RK, Mi Z, Gillespie DG and Jackson EK (1996b) Cyclic AMP-adenosine pathway inhibits vascular smooth muscle cell growth. Hypertension 28:765-771.
10. Ekas RD Jr, Steenberg ML, Eikenburg DC and Lokhandwala MF (1981) Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur J Pharmacol 76:301-307.
11. 3H]-adenine labelled rabbit kidney following sympathetic nerve stimulation, and its inhibition by α-adrenoceptor blockage. Br J Pharmacol 64:239-245.
12. Fujita T and Sato Y (1984) Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats. Am J Physiol 246:F670-F675.
13. Hedqvist P and Fredholm BB (1976) Effects of adenosine on adrenergic neurotransmission; Prejunctional inhibition and postjunctional enhancement. Naunyn-Schmiedeberg's Arch Pharmacol 293:217-223.
14. Hedqvist P, Fredholm BB and Olundh S (1978) Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res 43:592-598.
15. Hoffman BB and Lefkowitz RJ (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, in Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed. (Hardman JG, Limbird, LE, Molinoff PB, Ruddon RW and Gilman AG eds) pp 199-248, McGraw-Hill, New York.
16. Jackson EK (1991) Adenosine: Physiological brake on renin release. Annu Rev Pharmacol Toxicol 31:1-35.
17. Jackson EK (1997) Renal actions of purines, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 217-250, Wiley-Liss, New York.
18. Jackson EK, Mi Z, Gillespie DG and Dubey RK (1997) Metabolism of cAMP to adenosine in the renal vasculature J Pharmacol Exp Ther 283:177-182.
19. Janssen BJ, van Essen H, Vervoort-Peters LH, Struyker-Boudier HA and Smits JF (1989) Role of afferent renal nerves in spontaneous hypertension in rats. Hypertension 13:327-333.
20. Janssen BJ, Malpas SC, Burke SL and Head GA (1997) Frequency-dependent modulation of renal blood flow by renal nerve activity in conscious rabbits. Am J Physiol 273:R597-R608.
21. Katholi RE (1985) Renal nerves and hypertension: An update. Fed Proc 44:2846-2850.
22. Katholi RE, Naftilan AJ, Bishop SP and Oparil S (1983) Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion. Hypertension 5:427-435.
23. Katholi RE, Whitlow PL, Hageman GR and Woods WT (1984) Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertension 2:349-359.
24. Keeton TK and Campbell WB (1980) The pharmacologic alteration of renin release. Pharmacol Rev 32:81-227.
25. Kennedy C, Todorov LD, Mihaylova-Todorova S and Sneddon P (1997) Release of soluble nucleotidases: A novel mechanism for neurotransmitter inactivation? Trends Pharmacol Sci 18:263-266.
26. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 91:2226-2234.
27. Lakhlani PP, Amenta F, Napoleone P, Felici L and Eikenburg DC (1994) Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney. Br J Pharmacol 111:1296-1308.
28. Mi Z, Herzer WA, Zhang Y and Jackson EK (1994) 3-Isobutyl-1-methylxanthine decreases renal cortical interstitial levels of adenosine and inosine. Life Sci 54: PL-277-PL-282.
29. Mi Z and Jackson EK (1995) Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther 273:728-733.
30. Pearson JD and Gordon JL (1979) Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature (London) 281:384-386.
31. Prichard BN and Owens CW (1990) Mode of action of beta-adrenergic blocking drugs in hypertension. Clin Physiol Biochem 8:1-10.
32. Schrader J. Decking U and Stumpe T (1995) Cardiac energetics and adenosine formation, in Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology (Belardinelli L and Pelleg A eds) pp 169-177, Kluwer Academic Publishers, Boston.
33. Sneddon P and Westfall DP (1984) Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol (London) 347:561-580.
34. Takahashi H, Iyoda I, Yamasaki H, Takeda K, Okajima H, Sasaki S, Yoshimura M, Nakagawa M and Ijichi H (1984) Retardation of the development of hypertension in DOCA-salt rats by renal denervation. Jpn Circ J 48:567-574.
35. Todorov LD, Mihaylova-Todorova S, Westfall TD, Sneddon P, Kennedy C, Bjur RA and Westfall DP (1997) Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation. Nature 387:76-79.
36. von Kügelgen I and Starke K (1991) Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci 12:319-324.
37. Watson S and Arkinstall S (1994) The G-Protein Linked Receptor FactsBook. Academic Press, New York.
38. Williams LT and Lefkowitz RJ (1978) Receptor Binding Studies in Adrenergic Pharmacology. Raven Press, New York.
39. Winternitz SR, Katholi RE and Oparil S (1980) Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest 66:971-978.
40. Winternitz SR and Oparil S (1982) Importance of the renal nerves in the pathogenesis of experimental hypertension. Hypertension 4:III-108-III-115.
41. Yoneda H, Hisa H and Satoh S (1990) Effects of adenosine on adrenergically induced renal vasoconstriction in dogs. Eur J Pharmacol 176:109-116.
42. Zambraski EJ (1989) Renal nerves in renal sodium-retaining states: Cirrhotic ascites, congestive heart failure, nephrotic syndrome. Miner Electrolyte Metabol 15:88-96.